Literature DB >> 36268497

Pharmacological options for pain control in patients with vertebral fragility fractures.

Nuttan Kantilal Tanna1, Terence Ong2,3.   

Abstract

This review considers the evidence base and current knowledge for pharmacological treatment options that are available for pain control in patients with vertebral fractures sustained after a low trauma incident. Due care needs to be taken when considering prescribed options for pain control. The decision should be based on first establishing whether the presentation is one of acute severe pain at the time of a new vertebral fragility fracture incident or whether the complaint is one of the debilitating, longer term chronic back pain syndrome, accompanied by a clinical suspicion of a possible new fracture. The article also presents currently debated questions in this important area of clinical and patient care and will be of interest to the readership worldwide.
© 2022 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V.

Entities:  

Keywords:  Analgesia; Opioid; Osteoporosis; Pain; Vertebral fracture

Year:  2022        PMID: 36268497      PMCID: PMC9577215          DOI: 10.1016/j.afos.2022.09.003

Source DB:  PubMed          Journal:  Osteoporos Sarcopenia        ISSN: 2405-5255


  63 in total

1.  Use of pamidronate for acute pain relief following osteoporotic vertebral fractures.

Authors:  A J Abdulla
Journal:  Rheumatology (Oxford)       Date:  2000-05       Impact factor: 7.580

2.  The World Health Organization three-step analgesic ladder comes of age.

Authors:  Colette Reid; Andrew Davies
Journal:  Palliat Med       Date:  2004-04       Impact factor: 4.762

3.  Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis.

Authors:  M C Nevitt; P Chen; D P Kiel; J-Y Reginster; R K Dore; J R Zanchetta; E V Glass; J H Krege
Journal:  Osteoporos Int       Date:  2006-08-08       Impact factor: 4.507

Review 4.  The role of exercise in the treatment of osteoporosis.

Authors:  Mehrsheed Sinaki; Michael Pfeifer; Elisabeth Preisinger; Eiji Itoi; René Rizzoli; Steven Boonen; Piet Geusens; Helmut W Minne
Journal:  Curr Osteoporos Rep       Date:  2010-09       Impact factor: 5.096

Review 5.  The assessment of fracture risk.

Authors:  Aasis Unnanuntana; Brian P Gladnick; Eve Donnelly; Joseph M Lane
Journal:  J Bone Joint Surg Am       Date:  2010-03       Impact factor: 5.284

Review 6.  From the neuromatrix to the pain matrix (and back).

Authors:  G D Iannetti; A Mouraux
Journal:  Exp Brain Res       Date:  2010-07-06       Impact factor: 1.972

Review 7.  Assessment of pain.

Authors:  H Breivik; P C Borchgrevink; S M Allen; L A Rosseland; L Romundstad; E K Breivik Hals; G Kvarstein; A Stubhaug
Journal:  Br J Anaesth       Date:  2008-05-16       Impact factor: 9.166

Review 8.  Vertebral Fractures: Clinical Importance and Management.

Authors:  D L Kendler; D C Bauer; K S Davison; L Dian; D A Hanley; S T Harris; M R McClung; P D Miller; J T Schousboe; C K Yuen; E M Lewiecki
Journal:  Am J Med       Date:  2015-10-30       Impact factor: 4.965

9.  Vertebral fractures and their association with health-related quality of life, back pain and physical function in older women.

Authors:  Lisa Johansson; Daniel Sundh; Martin Nilsson; Dan Mellström; Mattias Lorentzon
Journal:  Osteoporos Int       Date:  2017-11-15       Impact factor: 4.507

10.  12-Month Teriparatide Treatment Reduces New Vertebral Compression Fractures Incidence And Back Pain And Improves Quality Of Life After Percutaneous Kyphoplasty In Osteoporotic Women.

Authors:  Meng Kong; Chuanli Zhou; Kai Zhu; Yiran Zhang; Mengxiong Song; Hao Zhang; Qihao Tu; Xuexiao Ma
Journal:  Clin Interv Aging       Date:  2019-10-01       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.